Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
The Prostate
|
March 16, 2023
Dynamic assessment of serum chromogranin A and treatment response with abiraterone acetate in metastatic castration-resistant prostate cancer
Akeem R Lewis, Brian A Costello, Fernando Quevedo, et al.
The Journal of Urology
|
June 20, 2023
The Impact of Metastasis Histopathology on Oncologic Outcomes for Patients With Surgically Resected Metastatic Renal Cell Carcinoma
Rodrigo Rodrigues Pessoa, Reza Nabavizadeh, Fernando Quevedo, et al.
The Journal of Urology
|
September 17, 2017
Identification of Recurrence Sites Following Post-Prostatectomy Treatment for Prostate Cancer Using <sup>11</sup>C-Choline Positron Emission Tomography and Multiparametric Pelvic Magnetic Resonance Imaging
Avinash Nehra, William P Parker, Rimki Haloi, et al.
Investigational New Drugs
|
July 27, 2013
Phase 1 study of sorafenib in combination with bortezomib in patients with advanced malignancies
Shaji K Kumar, James Jett, Randolph Marks, et al.
The Prostate
|
June 2, 2022
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases
Alex J Liu, Heidi E Kosiorek, Benjamin E Ueberroth, et al.
European Urology
|
August 18, 2014
Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer
Xiaoyi Huang, Tiezheng Yuan, Meihua Liang, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 21, 2025
[<sup>177</sup>Lu] Lu-PSMA-617 treatment for metastatic castration-resistant prostate cancer (mCRPC) with cerebral and cerebellar metastases
Gokce Belge Bilgin, Cem Bilgin, Brian J Burkett, et al.
Advances in Radiation Oncology
|
November 2, 2019
<sup>11</sup>C-Choline PET Guided Salvage Radiation Therapy for Isolated Pelvic and Paraortic Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Rationale and Early Genitourinary or Gastrointestinal Toxicities
Krishan R Jethwa, Christopher D Hellekson, Jaden D Evans, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 31, 2025
Defining NECTIN4 Amplification and Protein Expression in Urothelial Carcinoma and Histologic Subtypes
John C Cheville, Jacob J Orme, Sounak Gupta, et al.
Journal of Pain and Symptom Management
|
May 5, 2025
Olanzapine for Managing Side Effects From Antiangiogenic Tyrosine-Kinase Inhibitors
Regina M Koch, Miguel Muniz, Candy S Peskey, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
The Prostate
|
March 16, 2023
Dynamic assessment of serum chromogranin A and treatment response with abiraterone acetate in metastatic castration-resistant prostate cancer
Akeem R Lewis, Brian A Costello, Fernando Quevedo, et al.
The Journal of Urology
|
June 20, 2023
The Impact of Metastasis Histopathology on Oncologic Outcomes for Patients With Surgically Resected Metastatic Renal Cell Carcinoma
Rodrigo Rodrigues Pessoa, Reza Nabavizadeh, Fernando Quevedo, et al.
The Journal of Urology
|
September 17, 2017
Identification of Recurrence Sites Following Post-Prostatectomy Treatment for Prostate Cancer Using <sup>11</sup>C-Choline Positron Emission Tomography and Multiparametric Pelvic Magnetic Resonance Imaging
Avinash Nehra, William P Parker, Rimki Haloi, et al.
Investigational New Drugs
|
July 27, 2013
Phase 1 study of sorafenib in combination with bortezomib in patients with advanced malignancies
Shaji K Kumar, James Jett, Randolph Marks, et al.
The Prostate
|
June 2, 2022
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases
Alex J Liu, Heidi E Kosiorek, Benjamin E Ueberroth, et al.
European Urology
|
August 18, 2014
Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer
Xiaoyi Huang, Tiezheng Yuan, Meihua Liang, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 21, 2025
[<sup>177</sup>Lu] Lu-PSMA-617 treatment for metastatic castration-resistant prostate cancer (mCRPC) with cerebral and cerebellar metastases
Gokce Belge Bilgin, Cem Bilgin, Brian J Burkett, et al.
Advances in Radiation Oncology
|
November 2, 2019
<sup>11</sup>C-Choline PET Guided Salvage Radiation Therapy for Isolated Pelvic and Paraortic Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Rationale and Early Genitourinary or Gastrointestinal Toxicities
Krishan R Jethwa, Christopher D Hellekson, Jaden D Evans, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 31, 2025
Defining NECTIN4 Amplification and Protein Expression in Urothelial Carcinoma and Histologic Subtypes
John C Cheville, Jacob J Orme, Sounak Gupta, et al.
Journal of Pain and Symptom Management
|
May 5, 2025
Olanzapine for Managing Side Effects From Antiangiogenic Tyrosine-Kinase Inhibitors
Regina M Koch, Miguel Muniz, Candy S Peskey, et al.
Page
of 7